EUDA Health Holdings Warrant
EUDAW
11 hedge funds and large institutions have $96.7K invested in EUDA Health Holdings Warrant in 2023 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
6.28% more ownership
Funds ownership: 0% → 6.28% (+6.3%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
8% less funds holding
Funds holding: 12 → 11 (-1)
21% less capital invested
Capital invested by funds: $123K → $96.7K (-$26.5K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$24 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$48 |
| 2 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$37 |
EUDAW Hedge Fund Activity: Q3 2023 in Review
11 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in EUDA Health Holdings Warrant (EUDAW) for Q3 2023, worth a combined $96.7K — down 21% from $123K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of EUDAW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Wolverine Asset Management, adding an estimated $24. The largest seller was UBS Group, exiting entirely with an estimated $48 sold.
- 11 institutional investors held EUDA Health Holdings Warrant (EUDAW) as of Q3 2023, down from 12 in Q2 2023.
- Funds reported $96.7K of EUDA Health Holdings Warrant stock for Q3 2023, down 21% quarter-over-quarter.
- 0 funds opened new EUDA Health Holdings Warrant positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest EUDA Health Holdings Warrant buyer in Q3 2023 was Wolverine Asset Management, an estimated $24 added.
- The largest EUDA Health Holdings Warrant seller in Q3 2023 was UBS Group, an estimated $48 sold.
Based on aggregated 13F filings for Q3 2023.